Intra-articular instillation of corticosteroids in patients with rheumatoid arthritis (RA) is often followed by transient relief of symptoms and signs of local synovitis (Hollander, Brown, Jessar, and Brown, 1951; Ziff, Scull, Ford, McEwen, and Bunim, 1952) . The basis for this clinical improvement is not known and has not been comprehensively correlated with changes in the characteristic synovial fluid (SF) abnormalities of RA. Decreases in the SF acid phosphatase level and leucocyte count (Ziff and others, 1952; Lemperg, Beckman, and Beckman, 1971) and transient decreases in SF haemolytic complement (CH50) level (Hunder and McDuffie, 1972) have been reported after the intra-articular administration of a corticosteroid. The theoretical bases for these alterations include the ability of corticoids to suppress immune inflammation in vivo (Gell, 1955) , to inhibit leucocyte chemotaxis (Ward, 1966) and other leucocyte functions (Packer and Greendyke, 1960) in vitro, and to stabilize leucocyte and other cell lysosomal membranes (Weissmann and Dingle, 1961) . We therefore investigated the concomitants of the beneficial clinical effect of intraarticular corticosteroids in patients with RA, using serial SF leucocyte counts and acid phosphatase levels as a measure of inflammation. SF rheumatoid factor (RF) titres and complement levels were determined to assess local immune abnormalities.
Material and methods

PATIENT POPULATION
Twelve patients with the diagnosis of definite or classical RA (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) were studied. At the time of the study the patients had active disease (Lansbury, 1966) and, based on the results of the serum latex-fixation test for RF (Singer and Plotz, 1956) , were designated eit.ier RF (+) or RF (-). The twelve patients included nine RF (+) and three RF (-). PROCEDURE SF samples were collected before and 4 to 30 days (mean 15) after the intra-articular administration of 40 mg. methylprednisolone (Depo-Medrol, Upjohn Co.). In addition, for three of the patients, SF samples were obtained from the opposite knee into which saline instead of corticosteroid was administered. Local clinical abnormalities were assessed just before each knee aspiration and were assigned a composite grade based on a system with seven separately scored components:
Duration of knee morning stiffness (0-3 points), Knee pain (0-3),
Loss of walking ability (0-3), Local inflammation (0-1), Knee effusion (0-1), Knee limitation of motion (0-1)
Radiological damage (0-3).
The scores for all components were added to arrive at the knee composite grade which could have a maximum of 15 points. Each SF sample was analysed for total leucocyte count and differential, total protein, glucose, and mucin clot formation (Ropes and Bauer, 1953) . Immunological studies included total haemolytic complement, CH50 (Kent and Fife, 1963) (normal serum has a range of 150 to 250 units/ml.), C4 protein level (Ruddy, Carpenter, Muller-Eberhard, and Austen, 1968) (Britton, Ruddy, Corson, Sosman, Schur, and Austen, 1972) . SF acid phosphatase levels were measured by the method of Andersch and Szczypinski with p-nitrophenylphosphate (Sigma Chemical Co.) as the substrate (Andersch and Szczypinski, 1947) . (11), a rise in the leucocyte count after corticoid injection.
A decrease of at least 40 per cent. was observed in the levels ofSF acid phosphatase in ten ofthe fourteen patients who had paired determinations (Table II) . SF acid phosphatase from both knees of one patient (12) rose with clinical exacerbation, but the level in the corticoid-injected knee rose less than in the saline injected knee.
CLINICAL RESPONSE All but one patient (12), experienced alleviation of local symptoms and showed a fall in the knee clinical grade after the intra-articular administration of corticosteroids which persisted to the time of reaspiration of SF (Table II) (Hollander and others, 1951; Ziff and others, 1952) . Whether this action of corticoids is due simply to their potent antiinflammatory properties or to a local immunosuppressive action remains uncertain. In this study, synovial fluid samples were examined for levels of total haemolytic complement and C4 protein, titres of RF, and concentrations of acid phosphatase before and after the intra-articular administration of methylprednisolone. In three patients, the same measurements were made in the contralateral knee which did not receive corticosteroids. Improvement of local symptoms with decrease in swelling and effusion, disappearance of stiffness and increase in motion were seen within 24 hours after the intraarticular injection in eleven of twelve patients and persisted to the time ofrepeat synovial fluid aspiration (Table II) . The local clinical improvement was associated with a marked decrease in SF acid phosphatase level, SF leucocyte count, and percentage of polymorphonuclear leucocytes in most ofthe patients. SF total haemolytic complement, C4 protein level, and titre of RF were unchanged in 50 per cent. of the corticoid-treated patients and only one of these variables was altered in the other six patients. The fact that similar changes were observed in two out of three patients when SF was obtained from the contralateral saline-injected knee suggests either a systemic effect of the corticoid or an effect attributable to the process of aspiration and intra-articular injection alone.
The local anti-inflammatory action of intraarticular corticoids has previously been reported. Ziff and others (1952) reported that patients who had intra-articular hydrocortisone showed local relief of symptoms, decrease in SF levels ofaminotripeptidase, and diminished total SF leucocyte count, associated with a remission of symptoms lasting from 8 days to 3 months. Lemperg and others (1971) noted that the intra-articular injection of hydrocortisone was followed by a significant drop in SF acid phosphatase levels in patients with RA. The lowering of the SF levels of acid phosphatase in patients with RA after intra-articular steroids may represent an in vivo counterpart of the observations of Weissmann and Dingle (1961) on the lysosomal membrane stabilizing effect of corticosteroids. Hunder and McDuffie (1972) reported that intraarticular administration of hydrocortisone to patients with either RA, 'chronic indeterminate polyarthritis' of the knee and ankles, or arthritis associated with regional enteritis resulted in decreases in the synovial fluid titres of whole complement and the levels of C3 and C4 protein which correlated with a decrease in (Herman, Bradley, Ziff, and Smiley, 1971) , the elevated levels of SF anti-gamma globulin in patients with RA (Weissmann, Zurier, Spieler, and Goldstein, 1971) , the depressed levels of complement (Ruddy and others, 1969) , and the release oflysosomal enzymes from SF leucocytes which are phagocytosing IgG-anti IgG complexes (Allison, Smith, and Wood, 1955) suggest that immunological events may play a significant role in the inflammatory changes seen in rheumatoid synovitis. Neither SF complement levels nor RF titres were affected at the time of persistent clinical improvement after corticosteroids and therefore local immunosuppression has not been demonstrated. The mechanism of corticoid reduction of SF leucocyte counts and, in particular, of polymorphonuclear leucocytes, may be related in part to the known corticoid suppression of leucocyte chemotaxis. In vitro studies have suggested that steroids will diminish the infiltration of inflammatory cells into areas of injury by a direct effect on leucocyte motility (Ward, 1966; Ward, Cochrane, and MullerEberhard, 1965) . The low levels of complement and complement components found in SF from patients with RA may be the reflection of activation by IgG-RF complexes (Britton and others, 1972) of the complement sequence which can generate chemotactic factors for leucocytes (Ward and Hill, 1970) . In addition, neutral proteases from WBC lysosomes have been found to generate chemotactic activity from C3 (Taubman, Goldschmidt, and Lepow, 1970) and C5 (Ward and Hill, 1970) . These observations may help to explain both the usual accumulation of polymorphonuclear leucocytes in rheumatoid SF and the suppressive effect of corticoids. At the present time, it is not clear if intraarticular corticoid instillation interferes with the immune generation of chemotactic factors or simply suppresses leucocyte chemotactic response to the factors. This study suggests that transient local relief of signs and symptoms in RA synovitis after intraarticular administration of steroids may be related to blocking vectors of inflammation without altering the immunological process seen in this disease.
Summary
Synovial fluid from knee joints of twelve patients with rheumatoid arthritis were analysed before and 4 to 30 days after an intra-articular injection of methylprednisolone. After corticoid injection, clinical improvement was moderate in five patients and mild in six; one had an exacerbation in local disease. Six of the patients showed no alteration in synovial fluid CH50, C4 protein level, or rheumatoid factor titre, and the other six demonstrated a 50 per cent. or greater change in only one of these synovial fluid values. All but one of the ten patients with paired cell counts showed a decrease in the total synovial fluid leucocyte count and the percentage of polymorphonuclear leucocytes and all but three patients had a 40 per cent. or greater fall in synovial fluid acid phosphatase concentration following the corticoid injection. The data suggest that the transient improvement in clinical symptoms and signs which follows the intra-articular administration of corticosteroids is related to their anti-inflammatory action reflected in decreases in synovial fluid leucocyte counts and lysosomal enzyme levels without any alteration of the basic immune aberrations characteristic of rheumatoid synovitis. 
